Article
Immunohistochemical expression of Claudin18.2 in borderline and malignant gynecologic tumors: Results from a pilot study
2026-02-13
Abstract excerpt
<title>Abstract</title> <p>Background Claudin 18.2 (CLDN 18.2) is an emerging therapeutic target in gastrointestinal malignancies, but its expression in gynecologic mucinous tumors remains poorly characterized. Our study aimed to evaluate CLDN18.2 expression in borderline and malignant mucinous tumors of the female genital tract and to explore its potential clinical relevance. Methods Formalin-fixed paraffin-em...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32ab00ca-7cda-593b-946b-198ddbb496a1
- DOI
- 10.21203/rs.3.rs-8756545/v1
